Lorglumide sodium salt
CAS No. 1021868-76-7
Lorglumide sodium salt( CR-1409 sodium salt )
Catalog No. M26280 CAS No. 1021868-76-7
Lorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLorglumide sodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
-
DescriptionLorglumide sodium salt is a potent cholecystokinin (CCK) receptor antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsCR-1409 sodium salt
-
PathwayGPCR/G Protein
-
TargetCholecystokinin Receptor
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1021868-76-7
-
Formula Weight481.39
-
Molecular FormulaC22H31Cl2N2NaO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (207.73 mM)
-
SMILESCCCCCN(CCCCC)C(=O)C(CCC(=O)O[Na])NC(=O)c1ccc(Cl)c(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
L-365260
A potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM.
-
Methyl Linoleate
Methyl linoleate has antioxidant activity.
-
A-65186
A-65186 is an A-type glutamatergic cholecystokinin (CCK) antagonist used to study inflammation and gastrointestinal tract injury.
Cart
sales@molnova.com